Phase II trial of neoadjuvant zoladex [goserelin] and flutamide in bulky and non-bulky clinical study c carcinoma of the prostate
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2005
At a glance
- Drugs Flutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 27 Nov 2005 New trial record.